{"name":"Moat Biotechnology Corporation","slug":"moat-biotechnology-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE85QzVZdlg0Sl9XOUlkeXRoQm1MZmV5RDNOQk96ODNNYjdCc1g3Yl9QRjBPTDhWdVJSeTFhLTRmbTdrajE3djFySUFsMGJTQzl5am9jemtqOFRidmM?oc=5","date":"2026-04-02","type":"pipeline","source":"GuruFocus","summary":"ITRMF (Iterum Therapeutics) Moat Score : 2/10 (As of Apr. 05, 2026) - GuruFocus","headline":"ITRMF (Iterum Therapeutics) Moat Score : 2/10 (As of Apr. 05, 2026)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOc1VkWVF2Zkh2X2pUQzlxMWhHbHpHcmpHRzFRaFpfbTlOLTI3Rk9tM0VyaFVJM3BUQThjYXZaZ3hsdlFBamx5ODhaaWl6R0tyRk1nSjEzRFFFVlp5TzA0N3VfRWY5d0YxNVhTajFmcS1yZDkwdnFKblB4VEJGSmg5dTcwOTZ2dw?oc=5","date":"2026-04-01","type":"pipeline","source":"Morningstar Canada","summary":"Best- and Worst-Performing Danish Stocks - Morningstar Canada","headline":"Best- and Worst-Performing Danish Stocks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE53Ulc0MVRkanRrTk40aHM3OVZvMGVnbjZsNlBIdldiTGhNSW50Q2Vkel9nbVlTWks5SWVvSUMxTVM5YTR5a0FuMDV5WEhQSnRUUG1pTTZYbmJUcWhaSS1yaFZMZG5kZmxBaU5oUkZn?oc=5","date":"2026-03-05","type":"deal","source":"Morningstar","summary":"The Best Healthcare Stocks to Buy - Morningstar","headline":"The Best Healthcare Stocks to Buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxNeHdydzdMRlNKOVd6NGlxVDNuVjZQU2p6OFI3dXdYRkMwY2p3ckNaQ25FbFF2UXVSY1B1NTY1N1laYjVHOU5CYVlWRzFRYTUtOVRNUlpNV3N5dWxGSEJ5MnVSekRQNW5BekhUeXVKel9UR0pFSEpQVVVwZzlLa3lyaGFKZ0x0elB3LVhoSXBBQzNILVVscmJuNHZzUlJKakRqbVdsdG1WcWZMUUxYZUNsdW90Mi14bXVOVGxFdjZBdHhUV0phS2cwckh4RDlVSG9CXzdYTjdKZzlURmM?oc=5","date":"2026-02-26","type":"pipeline","source":"NAI500","summary":"Analysts See 3x Upside Potential, Overlooked Cancer Diagnostics Company Telix Could Be an Investment Dark Horse - NAI500","headline":"Analysts See 3x Upside Potential, Overlooked Cancer Diagnostics Company Telix Could Be an Investment Dark Horse - NAI500","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxPa2VCQVJaZUp0V2toSWFJTDluZXlUeFRXWG5faGp1c210RnMxeW8xX0phNGFUUTkzS1lqbDlHQ2ptdXdCYllhVXh1RWowbFR4M3hhdVZFX1RnX01RdU5HSnJiZ0xjNkNMWXdMd1BBcmRuT1E1dGx0b0NaVllnWW1veWk4eDVjS0lNOHo2eFljU1ZMX3dMRmNOLWdCQ1ZSUEdxLVdXWkk3MWlBRnNNLXIzbms2S0tXQVI3QW0wMDU3UEhLNU05UkpaNTV6cUU3ODZndEV3Yw?oc=5","date":"2026-02-06","type":"pipeline","source":"VanEck","summary":"How AI Is Reshaping Drug Discovery and Healthcare Investing - VanEck","headline":"How AI Is Reshaping Drug Discovery and Healthcare Investing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE1LVzQxbTd5SlM0VzVDWWU4dGxVUUk1SGFkc3RncGc4OFB5dTJfN1VQS3pzVGVWV3RtZjJ5NHBRc3FqLVBBTmMzS2pKRkxiQXhEeEhPWGs2ejVmTlRQUkZiRDhaTmg1TVNpRmc?oc=5","date":"2026-02-05","type":"deal","source":"Morningstar","summary":"The Best Biotech Stocks to Buy - Morningstar","headline":"The Best Biotech Stocks to Buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOOGwxdHVqa2pYQ2U1Y21OU3VkYzdFdWRtZG5tSnlYZTI0XzJJZkxZM1BaVmk1MEoyOEFHYmtUUTB6ZGtISTVHWUhHRTNIc0wxU2ZDZHJ0ZkNhSjJRSnZ0ZXZRR19sc0F5aldmMDJ0S2l0aVAweXJuREkzQ0k4MEtsRWNweXpDWkRXTExoMXlkQ1JCdnlSVnR1RVlHQkR3aXo0?oc=5","date":"2026-01-16","type":"pipeline","source":"VanEck","summary":"Stage Set for Moat Stocks After Strong 2025 Close - VanEck","headline":"Stage Set for Moat Stocks After Strong 2025 Close","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQbkRoU2d0TDNnWUI3UENneU1mZHlrc0I4QmZMRmdmS3JQODk1OUVIc2U1akdvZVl1ZElhcWwydkxrd01vWTlpWnFGUFNGdmpkSzhjU3BHSld4dXhZNE9Oa2x0NHJ0bmNXdTN5a3lZNi1yeGpsTko2bkJsTERNOXpZVmF1ZzdvVVJpNmE4OTA2cw?oc=5","date":"2026-01-13","type":"pipeline","source":"seekingalpha.com","summary":"Stage Set For Moat Stocks After Strong 2025 Close - seekingalpha.com","headline":"Stage Set For Moat Stocks After Strong 2025 Close","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQR0FENVZuSmVpOGxodFdWSXFOVWpMYzlNZHM2bERBeThCd3R0ZnJFVHpqQjFibUNYZU10OGxHczdxME9kdEVBQVVVdk9FeFl6a1Q3aEFrN1lVQ2dieFJwZV9JVVJWWm5DNURuVWppaE1IaFBtN3prSEJGekdoWkV1UE5NU05Nc0ZCWW1uVQ?oc=5","date":"2025-12-13","type":"deal","source":"The Motley Fool","summary":"My Top 3 Healthcare Stocks to Buy in 2026 - The Motley Fool","headline":"My Top 3 Healthcare Stocks to Buy in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOeEdLVWx4a3A1OTA3LXJ3OTFHTGpqVVRZSnp2WWVQVFptN3NKMENSZXFDcU1Dc000ZFQxc05Eakp5VnNhcVY5NkNMeE1UMm9IZkQ3bjJ5WS1WeFR4Y3ZTSFl5OW81ckh6dDRWOUMwTlJSRVZwVWNOc2J1dFFMVnFPeHpsVTA2Q1EwT0hrRXR4RFBCSENQSXpXVC1uUlV1clFIZ3lPenNhc0RXZGVORjdMSFNLTjNKU3hp?oc=5","date":"2025-10-06","type":"pipeline","source":"seekingalpha.com","summary":"Adaptive Biotechnologies: Current Moat Is Strong, But Value Rides On Long-Term Innovation (Rating Upgrade) - seekingalpha.com","headline":"Adaptive Biotechnologies: Current Moat Is Strong, But Value Rides On Long-Term Innovation (Rating Upgrade)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQN3hxUGtXdXk3TUl6QzQ5VXlnTVNmaG1sdGtkMndpcDRQWTBURWRtbTY0bVFBZDZKc1NSa2ZJRWdqb0g3Wm1uS3pJeFdUZDlBM3Q3RjhtLTBRWWJ2WnZxZGstcGc2ZkhpNjB6blh1cHBuUE9xUFEwMDFYVExzS253a2JoX3ZWTHJMckVaRUthMWtRd2cybVZ3dE5pcDBObkJWOHBzRW56dUloM05ZYmZJ?oc=5","date":"2023-06-13","type":"pipeline","source":"BioSpace","summary":"Moat Biotechnology Raises $6.5M in First Close for Intranasal/Inhaled Covid-19 Vaccine - BioSpace","headline":"Moat Biotechnology Raises $6.5M in First Close for Intranasal/Inhaled Covid-19 Vaccine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1FOTY1XzdwN0g1OUpxUHYtUjNVbENMR2hNbTIxanF3SUx3bWdMSHpReTRvek5WRnZVamxVQlJrMndISzVlWUs0NktPQUlBZjNtSmU2b2R3Tmdqa0ZKVjBQR1Y5eDlxN1BvVGFHXzFQcllyMWNhaUZrX3hSWQ?oc=5","date":"2022-09-21","type":"trial","source":"Clinical Trials Arena","summary":"Moat reports initial Phase I data for intranasal Covid-19 vaccine - Clinical Trials Arena","headline":"Moat reports initial Phase I data for intranasal Covid-19 vaccine","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}